NASDAQ

Grace Therapeutics, Inc. (GRCE)

♥ 664 Thanks from members

Live price chart, market sentiment, and community perspectives for Grace Therapeutics, Inc. (NASDAQ: GRCE).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Health CareIndustry: BiotechnologyFounder: Grace Therapeutics ManagementLeadership: Vipin K. Garg (CEO)Holder: Institutional Private EquityHolder: InsidersProprietary Drug Delivery FormulationsNeurology Therapeutics#GRCE stock#Grace Therapeutics#biotech clinical stage#drug delivery#NASDAQ GRCE